About PAVmed
PAVmed is a company based in New York (United States) founded in 2014.. PAVmed has raised $845 thousand across 12 funding rounds from investors including HHS. The company has 39 employees as of December 31, 2024. PAVmed offers products and services including Lucid Diagnostics and Veris Health. PAVmed operates in a competitive market with competitors including Medtronic, GE Healthcare, Boston Scientific, Guardant Health and Johnson & Johnson, among others.
- Headquarter New York, United States
- Employees 39 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pavmed Inc.
-
Annual Revenue
$3 M22.15as on Dec 31, 2024
-
Net Profit
$39.79 M162.01as on Dec 31, 2024
-
EBITDA
$-43.29 M34.27as on Dec 31, 2024
-
Total Equity Funding
$845 K (USD)
in 12 rounds
-
Latest Funding Round
$2.37 M (USD), Post-IPO
Feb 21, 2025
- Investors
-
Employee Count
39
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of PAVmed
PAVmed is a publicly listed company on the NASDAQ with ticker symbol PAVM in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of PAVmed
PAVmed offers a comprehensive portfolio of products and services, including Lucid Diagnostics and Veris Health. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides tests for detecting esophageal precancer.
Offers remote monitoring for personalized cancer care.
Unlock access to complete
Unlock access to complete
Funding Insights of PAVmed
PAVmed has successfully raised a total of $845K across 12 strategic funding rounds. The most recent funding activity was a Post-IPO round of $2.37 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Post-IPO — $2.4M
-
First Round
First Round
(23 Nov 2014)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2025 | Amount | Post-IPO - PAVmed | Valuation |
investors |
|
| Jan, 2025 | Amount | Post-IPO - PAVmed | Valuation |
investors |
|
| Sep, 2024 | Amount | Grant - PAVmed | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PAVmed
PAVmed has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PAVmed
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PAVmed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pavmed Comparisons
Competitors of PAVmed
PAVmed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medtronic, GE Healthcare, Boston Scientific, Guardant Health and Johnson & Johnson, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical equipment for treating over 30 chronic diseases is developed.
|
|
| domain | founded_year | HQ Location |
Materials management solutions are provided for healthcare organizations.
|
|
| domain | founded_year | HQ Location |
Wide range of medical devices
|
|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Healthcare solutions are provided by Johnson & Johnson globally.
|
|
| domain | founded_year | HQ Location |
Diagnostic and surgical products for women's healthcare are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pavmed
Frequently Asked Questions about PAVmed
When was PAVmed founded?
PAVmed was founded in 2014.
Where is PAVmed located?
PAVmed is headquartered in New York, United States. It is registered at New York, New York, United States.
Is PAVmed a funded company?
PAVmed is a funded company, having raised a total of $845K across 12 funding rounds to date. The company's 1st funding round was a Grant of $892.11K, raised on Nov 23, 2014.
How many employees does PAVmed have?
As of Dec 31, 2024, the latest employee count at PAVmed is 39.
What is the annual revenue of PAVmed?
Annual revenue of PAVmed is $3M as on Dec 31, 2024.
What does PAVmed do?
Developer of medical devices and biomarkers to detect various diseases. The products developed by the company include CarpX a minimally invasive device to treat carpal tunnel syndrome, PortIO a novel, implantable, intraosseous vascular access device, and DisappEAR antimicrobial resorbable ear tubes, and many more.
Who are the top competitors of PAVmed?
PAVmed's top competitors include Guardant Health, GRAIL and GE Healthcare.
What products or services does PAVmed offer?
PAVmed offers Lucid Diagnostics and Veris Health.
Is PAVmed publicly traded?
Yes, PAVmed is publicly traded on NASDAQ under the ticker symbol PAVM.
Who are PAVmed's investors?
PAVmed has 1 investor. Key investors include HHS.
What is PAVmed's ticker symbol?
The ticker symbol of PAVmed is PAVM on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.